Thermo Fisher Scientific Inc. (TMO) — Analyst outlook / Analyst consensus target is. Based on 42 analyst ratings, the consensus is bullish — 38 Buy, 4 Hold.
The consensus price target is $650.58 (low: $575.00, high: $750.00), representing an upside of 23.4% from the current price $527.22.
Analysts estimate Earnings Per Share (EPS) of $21.70 and revenue of $42.77B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $16.58 vs est $21.70 (missed -23.6%). 2025: actual $17.77 vs est $22.75 (missed -21.9%). Analyst accuracy: 71%.
TMO Stock — 12-Month Price Forecast
$650.58
▲ +23.40% Upside
Average Price Target
Based on 42 Wall Street analysts offering 12-month price targets for Thermo Fisher Scientific Inc., the average price target is $650.58, with a high forecast of $750.00, and a low forecast of $575.00.
The average price target represents a +23.40% change from the last price of $527.22.
Highest Price Target
$750.00
Average Price Target
$650.58
Lowest Price Target
$575.00
TMO Analyst Ratings
Buy
Based on 42 analysts giving stock ratings to Thermo Fisher Scientific Inc. in the past 3 months
EPS Estimates — TMO
71%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $16.58
vs Est $21.70
▼ 30.9% off
2025
Actual $17.77
vs Est $22.75
▼ 28.0% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — TMO
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $42.879B
vs Est $42.771B
▲ 0.3% off
2025
Actual $44.556B
vs Est $44.287B
▲ 0.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
